REQUEST A DEMO
Total
USD $0.00
Search more companies

Stada Pharma Slovakia, s. r. o. (Slovakia)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Stada Pharma Slovakia, s. r. o. Profile Updated: April 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Stada Pharma Slovakia, s. r. o. is an enterprise in Slovakia, with the main office in Bratislava. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. Stada Pharma Slovakia, s. r. o. was incorporated on January 19, 2008. 50 - 99 (2023) employees currently work for Stada Pharma Slovakia, s. r. o.. The company’s latest financial report indicates a net sales revenue increase of 11.95% in 2023. Its’ total assets recorded a growth of 27.56%. In 2023, Stada Pharma Slovakia, s. r. o.’s net profit margin decreased by 1.31%.

Headquarters
Digital Park III, Einsteinova 19
Bratislava; Bratislavsky; Postal Code: 85101

Contact Details: Purchase the Stada Pharma Slovakia, s. r. o. report to view the information.

Basic Information
Total Employees:
Purchase the Stada Pharma Slovakia, s. r. o. report to view the information.
Outstanding Shares:
Purchase the Stada Pharma Slovakia, s. r. o. report to view the information.
Registered Capital:
Purchase the Stada Pharma Slovakia, s. r. o. report to view the information.
Incorporation Date:
January 19, 2008
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Stada Pharma Slovakia, s. r. o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
11.95%
Total operating revenue
11.96%
Operating profit (EBIT)
-23.37%
EBITDA
-22.07%
Net Profit (Loss) for the Period
-40.2%
Total assets
27.56%
Total equity
-10.31%
Operating Profit Margin (ROS)
-1.31%
Net Profit Margin
-1.31%
Return on Equity (ROE)
-8.55%
Debt to Equity Ratio
-0.09%
Quick Ratio
-0.14%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?